A survey of patients w/ stomach dysplasia shows they are at an 11-fold risk for gastric cancer & that the median time to development of cancer was 4 years
Compared with surgery alone, neoadjuvant chemotherapy followed by surgery was not associated with a higher rate of overall survival or complete resection